We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+22.98%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$2.69B
AUM Growth
+$481M
Cap. Flow
+$129M
Cap. Flow %
4.79%
Top 10 Hldgs %
44.27%
Holding
113
New
25
Increased
16
Reduced
30
Closed
12

Top Buys

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$32.8M
2
AAPL icon
Apple
AAPL
+$32.1M
3
AVBP icon
ArriVent BioPharma
AVBP
+$31.5M
4
ARGX icon
argenx
ARGX
+$26.4M
5
CRH icon
CRH
CRH
+$25.7M

Top Sells

Rank Stock Value
1
ACLX
Arcellx
ACLX
+$55.4M
2
RPRX icon
Royalty Pharma
RPRX
+$48.3M
3
LVS icon
Las Vegas Sands
LVS
+$36.3M
4
MSFT icon
Microsoft
MSFT
+$33.4M
5
TERN
Terns Pharmaceuticals
TERN
+$29.2M

Sector Composition

Rank Sector Weight
1 Healthcare 57.97%
2 Technology 7.85%
3 Communication Services 7.05%
4 Consumer Discretionary 4.46%
5 Financials 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVTR icon
76
Avantor
AVTR
$9.19B
$1.84M 0.07%
71,850
+33,600
+88% +$799K
IQV icon
77
IQVIA
IQV
$39.3B
$1.81M 0.07%
7,175
– –
MOLN
78
Molecular Partners
MOLN
$1.68M 0.06%
400,000
– –
SYK icon
79
Stryker
SYK
$130B
$1.56M 0.06%
4,360
– –
MDT icon
80
Medtronic
MDT
$112B
$1.52M 0.06%
17,460
– –
LKFT
81
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
$1.52M 0.06%
47,200
– –
CVS icon
82
CVS Health
CVS
$122B
$1.37M 0.05%
17,170
– –
ILMN icon
83
Illumina
ILMN
$28.4B
$1.2M 0.04%
8,974
– –
AKLI
84
DELISTED
Akili Inc
AKLI
$1.11M 0.04%
3,841,718
– –
WAT icon
85
Waters Corp
WAT
$39.9B
$1.08M 0.04%
3,150
– –
BNTC icon
86
Benitec Biopharma
BNTC
$468M
$1.07M 0.04%
204,220
– –
HCA icon
87
HCA Healthcare
HCA
$89.5B
$1.06M 0.04%
+3,190
New +$975K
EW icon
88
Edwards Lifesciences
EW
$51.7B
$1.06M 0.04%
+11,100
New +$932K
PTGX icon
89
Protagonist Therapeutics
PTGX
$9.44B
$882K 0.03%
+30,500
New +$830K
DXCM icon
90
DexCom
DXCM
$32B
$816K 0.03%
5,880
– –
A icon
91
Agilent Technologies
A
$41.2B
$726K 0.03%
4,990
– –
MS icon
92
Morgan Stanley
MS
$340B
$719K 0.03%
7,641
+2,841
+59% +$250K
HUM icon
93
Humana
HUM
$46.2B
$676K 0.03%
+1,950
New +$739K
VLTO icon
94
Veralto
VLTO
$24B
$485K 0.02%
5,475
– –
RMD icon
95
ResMed
RMD
$30.7B
$473K 0.02%
+2,390
New +$438K
IONS icon
96
Ionis Pharmaceuticals
IONS
$9.4B
$468K 0.02%
+10,800
New +$515K
ZBH icon
97
Zimmer Biomet
ZBH
$18.4B
$430K 0.02%
+3,260
New +$407K
ALGN icon
98
Align Technology
ALGN
$12.3B
$361K 0.01%
+1,100
New +$323K
STE icon
99
Steris
STE
$23.1B
$344K 0.01%
+1,530
New +$345K
BAX icon
100
Baxter International
BAX
$14.2B
$341K 0.01%
+7,970
New +$324K
1 2 3
4
5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Suvretta Capital Management held 113 positions worth $2.69B, up 22% from $2.21B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Suvretta Capital Management deployed $129M of net new capital in Q1 2024, opening 25 new positions and adding to 16 existing holdings. Its largest new stake was Coca-Cola: 546,500 shares worth $33.4M.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, down from 68% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Arcellx, an estimated $55.4M trimmed.

  • Suvretta Capital Management's largest Q1 2024 buy was Coca-Cola: 546,500 shares worth $33.4M.
  • Suvretta Capital Management added most to argenx in Q1 2024, an estimated $26.4M increase.
  • Suvretta Capital Management's biggest Q1 2024 reduction was Arcellx, cutting an estimated $55.4M.
  • Suvretta Capital Management fully exited Las Vegas Sands in Q1 2024, selling an estimated $36.3M.
  • Suvretta Capital Management's ten largest holdings make up 44% of its $2.69B portfolio in Q1 2024.
  • Suvretta Capital Management opened 25 new positions and closed 12 in Q1 2024.
  • Suvretta Capital Management's portfolio value rose 22% quarter-over-quarter to $2.69B.

Based on Suvretta Capital Management's 13F filing for Q1 2024, filed 15 May 2024.